These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

242 related items for PubMed ID: 31102031

  • 1. A Single Hydrogen to Fluorine Substitution Reverses the Trend of Surface Composition Enrichment of Sorafenib Amorphous Solid Dispersion upon Moisture Exposure.
    Chen Y, Chen H, Wang S, Liu C, Qian F.
    Pharm Res; 2019 May 17; 36(7):105. PubMed ID: 31102031
    [Abstract] [Full Text] [Related]

  • 2. Impact of a Single Hydrogen Substitution by Fluorine on the Molecular Interaction and Miscibility between Sorafenib and Polymers.
    Liu C, Xu CQ, Yu J, Pui Y, Chen H, Wang S, Zhu AD, Li J, Qian F.
    Mol Pharm; 2019 Jan 07; 16(1):318-326. PubMed ID: 30511872
    [Abstract] [Full Text] [Related]

  • 3. Phase Behavior of Ritonavir Amorphous Solid Dispersions during Hydration and Dissolution.
    Purohit HS, Taylor LS.
    Pharm Res; 2017 Dec 07; 34(12):2842-2861. PubMed ID: 28956218
    [Abstract] [Full Text] [Related]

  • 4. Moisture-Induced Amorphous Phase Separation of Amorphous Solid Dispersions: Molecular Mechanism, Microstructure, and Its Impact on Dissolution Performance.
    Chen H, Pui Y, Liu C, Chen Z, Su CC, Hageman M, Hussain M, Haskell R, Stefanski K, Foster K, Gudmundsson O, Qian F.
    J Pharm Sci; 2018 Jan 07; 107(1):317-326. PubMed ID: 29107047
    [Abstract] [Full Text] [Related]

  • 5. Phase behavior of poly(vinylpyrrolidone) containing amorphous solid dispersions in the presence of moisture.
    Rumondor AC, Marsac PJ, Stanford LA, Taylor LS.
    Mol Pharm; 2009 Jan 07; 6(5):1492-505. PubMed ID: 19634917
    [Abstract] [Full Text] [Related]

  • 6. Effect of temperature and moisture on the miscibility of amorphous dispersions of felodipine and poly(vinyl pyrrolidone).
    Marsac PJ, Rumondor AC, Nivens DE, Kestur US, Stanciu L, Taylor LS.
    J Pharm Sci; 2010 Jan 07; 99(1):169-85. PubMed ID: 19492305
    [Abstract] [Full Text] [Related]

  • 7. Initial Drug Dissolution from Amorphous Solid Dispersions Controlled by Polymer Dissolution and Drug-Polymer Interaction.
    Chen Y, Wang S, Wang S, Liu C, Su C, Hageman M, Hussain M, Haskell R, Stefanski K, Qian F.
    Pharm Res; 2016 Oct 07; 33(10):2445-58. PubMed ID: 27283830
    [Abstract] [Full Text] [Related]

  • 8. Effect of Variability of Physical Properties of Povidone K30 on Crystallization and Drug-Polymer Miscibility of Celecoxib-Povidone K30 Amorphous Solid Dispersions.
    Phadke C, Sharma J, Sharma K, Bansal AK.
    Mol Pharm; 2019 Oct 07; 16(10):4139-4148. PubMed ID: 31454247
    [Abstract] [Full Text] [Related]

  • 9. Solubility advantage from amorphous etoricoxib solid dispersions.
    Dani P, Puri V, Bansal AK.
    Drug Dev Ind Pharm; 2014 Jan 07; 40(1):92-101. PubMed ID: 23301771
    [Abstract] [Full Text] [Related]

  • 10. Effect of Temperature and Moisture on the Physical Stability of Binary and Ternary Amorphous Solid Dispersions of Celecoxib.
    Xie T, Taylor LS.
    J Pharm Sci; 2017 Jan 07; 106(1):100-110. PubMed ID: 27476771
    [Abstract] [Full Text] [Related]

  • 11. Amorphous solid dispersion of nisoldipine by solvent evaporation technique: preparation, characterization, in vitro, in vivo evaluation, and scale up feasibility study.
    Chavan RB, Lodagekar A, Yadav B, Shastri NR.
    Drug Deliv Transl Res; 2020 Aug 07; 10(4):903-918. PubMed ID: 32378174
    [Abstract] [Full Text] [Related]

  • 12. Theoretical and experimental investigation of drug-polymer interaction and miscibility and its impact on drug supersaturation in aqueous medium.
    Baghel S, Cathcart H, O'Reilly NJ.
    Eur J Pharm Biopharm; 2016 Oct 07; 107():16-31. PubMed ID: 27378287
    [Abstract] [Full Text] [Related]

  • 13. Moisture sorption by polymeric excipients commonly used in amorphous solid dispersion and its effect on glass transition temperature: I. Polyvinylpyrrolidone and related copolymers.
    Patel NG, Serajuddin ATM.
    Int J Pharm; 2022 Mar 25; 616():121532. PubMed ID: 35121046
    [Abstract] [Full Text] [Related]

  • 14. Phase Behavior of Amorphous Solid Dispersions of Felodipine: Homogeneity and Drug-Polymer Interactions.
    Sarpal K, Delaney S, Zhang GGZ, Munson EJ.
    Mol Pharm; 2019 Dec 02; 16(12):4836-4851. PubMed ID: 31682129
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Solvent-shift strategy to identify suitable polymers to inhibit humidity-induced solid-state crystallization of lacidipine amorphous solid dispersions.
    Sun M, Wu C, Fu Q, Di D, Kuang X, Wang C, He Z, Wang J, Sun J.
    Int J Pharm; 2016 Apr 30; 503(1-2):238-46. PubMed ID: 26869398
    [Abstract] [Full Text] [Related]

  • 18. Forced Solid-State Oxidation Studies of Nifedipine-PVP Amorphous Solid Dispersion.
    Saraf I, Roskar R, Modhave D, Brunsteiner M, Karn A, Neshchadin D, Gescheidt G, Paudel A.
    Mol Pharm; 2022 Feb 07; 19(2):568-583. PubMed ID: 35060741
    [Abstract] [Full Text] [Related]

  • 19. Understanding the generation and maintenance of supersaturation during the dissolution of amorphous solid dispersions using modulated DSC and 1H NMR.
    Baghel S, Cathcart H, O'Reilly NJ.
    Int J Pharm; 2018 Jan 30; 536(1):414-425. PubMed ID: 29183857
    [Abstract] [Full Text] [Related]

  • 20. Effect of polymer content and molecular weight on the morphology and heat- and moisture-induced transformations of spray-dried composite particles of amorphous lactose and poly(vinylpyrrolidone).
    Berggren J, Alderborn G.
    Pharm Res; 2003 Jul 30; 20(7):1039-46. PubMed ID: 12880290
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.